Acomplia and Steven Nissen

The rejection of Acomplia doesn’t make crusader Steven Nissen look good:

That means it’s at least the second time in under a year that Steven Nissen has been wrong about the promise of new drugs. Nissen, of course, is the well-known Cleveland Clinic cardiologist whose efforts were largely responsible for toppling Vioxx, and he just co-authored a NEJM study raising serious doubts about Avandia.

He was also optimistic about Pfizer-dud torcetrapib. (via WSJ Health Blog)